By Justin Petrone

Oxford Gene Technology will later this month introduce an array with copy number variant and SNP content that it claims can be used to study a number of hematological malignancies, including chronic lymphocytic leukemia and multiple myeloma.

Additionally, the new array includes content that can be used to investigate myeloproliferative neoplasms and myelodysplatic syndromes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.